Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis
Wenchun Qu, Zhen Wang, Erica Engelberg-Cook, et al.
Stem Cells Translational Medicine (2022) Vol. 11, Iss. 7, pp. 688-703
Open Access | Times Cited: 16

Showing 16 citing articles:

Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery
Pedro Silva Couto, Nada Al-Arawe, Igor Salerno Filgueiras, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Clinical application prospects and transformation value of dental follicle stem cells in oral and neurological diseases
Chao Yang, Xinya Du, Wen Luo
World Journal of Stem Cells (2023) Vol. 15, Iss. 4, pp. 136-149
Open Access | Times Cited: 9
Universal or Personalized Mesenchymal Stem Cell Therapies: Impact of Age, Sex, and Biological Source
Diana M. Carp, Yun Liang
Cells (2022) Vol. 11, Iss. 13, pp. 2077-2077
Open Access | Times Cited: 15
Mesenchymal stem cell therapy for COVID-19 infection
Seyyed Mohammad Matin Alavi-Dana, Yazdan Gholami, Mohammadreza Meghdadi, et al.
Inflammopharmacology (2023) Vol. 32, Iss. 1, pp. 319-334
Closed Access | Times Cited: 6
Successful treatment with mesenchymal stem cells for steroid-refractory late-onset idiopathic pneumonia syndrome following allogeneic hematopoietic cell transplantation
Soichiro Nakako, Hideo Koh, Nobuhiro Sogabe, et al.
Transplant Immunology (2024) Vol. 86, pp. 102107-102107
Closed Access | Times Cited: 1
Short-term assays for mesenchymal stromal cell immunosuppression of T-lymphocytes
Maryanne C. Herzig, Barbara A. Christy, Robbie K. Montgomery, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Adipose-derived, autologous mesenchymal stem cell therapy for patients with post-COVID-19 syndrome: an intermediate-size expanded access program
Ridhima Vij, Hosu Kim, Hyeonggeun Park, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Efficacy of umbilical cord mesenchymal stromal cells for COVID-19: A systematic review and meta-analysis
Cong-wen Yang, Rudong Chen, Qing-run Zhu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Development and characterization of islet‐derived mesenchymal stem cells from clinical grade neonatal porcine cryopreserved islets
Takeshi Kikuchi, Masuhiro Nishimura, Natsuki Komori, et al.
Xenotransplantation (2023)
Open Access | Times Cited: 3
Relationship between oxygen partial pressure and inhibition of cell aggregation of human adipose tissue-derived mesenchymal stem cells stored in cell preservation solutions
Takeshi Kikuchi, Masuhiro Nishimura, Chikage Shirakawa, et al.
Regenerative Therapy (2023) Vol. 24, pp. 25-31
Open Access | Times Cited: 2
Avoiding aggregation of human bone marrow–derived mesenchymal stem cells stored in cell preservation solutions
Takeshi Kikuchi, Masuhiro Nishimura, Chikage Shirakawa, et al.
In Vitro Cellular & Developmental Biology - Animal (2024) Vol. 60, Iss. 2, pp. 123-127
Open Access
Stem cell therapy for COVID-19 treatment: An umbrella review
Chaozhi Tang, Arkadiusz Dziedzic, Mahalaqua Nazli Khatib, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 10, pp. 6402-6417
Open Access
Update on the Clinical Applications of Mesenchymal Stem Cells
Al-Anazi Khalid Ahmed
Journal of Stem Cell Therapy and Transplantation (2023) Vol. 7, Iss. 1, pp. 043-064
Open Access | Times Cited: 1
Rationale for combined therapies in severe-to-critical COVID-19 patients
Aitor Gonzaga, Etelvina Andreu, Luis Blasco, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Dissecting the Interrelationship between COVID‐19 and Diabetes Mellitus
Pratiksha H. Roham, Jayesh Kamath, Shilpy Sharma
Advanced Biology (2023) Vol. 7, Iss. 8
Closed Access
Análise compreensiva da resposta imune às infecções por ZIKV e SARS-CoV-2 em diferentes contextos patológicos
Igor Salerno Filgueiras
(2023)
Open Access
Page 1

Scroll to top